Nancy Bartlett

2023

Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma

Nastoupil, L. J. & Bartlett, N. L., Feb 1 2023, In: Journal of Clinical Oncology. 41, 4, p. 903-913 11 p.

Research output: Contribution to journal › Review article › peer-review

27 Scopus citations

2021

Optimizing Second-Line Therapy for Hodgkin Lymphoma: A Work in Progress

Bartlett, N. L., Oct 1 2021, In: Journal of Clinical Oncology. 39, 28, p. 3097-3103 7 p.

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

2020

Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial

Thanarajasingam, G., Leonard, J. P., Witzig, T. E., Habermann, T. M., Blum, K. A., Bartlett, N. L., Flowers, C. R., Pitcher, B. N., Jung, S. H., Atherton, P. J., Tan, A., Novotny, P. J. & Dueck, A. C., Jun 2020, In: The Lancet Haematology. 7, 6, p. e490-e497

Research output: Contribution to journal › Review article › peer-review

Open Access

19 Scopus citations

2018

CD19-targeted immunotherapies for treatment of patients with non-Hodgkin B-cell lymphomas

Watkins, M. P. & Bartlett, N. L., Jul 3 2018, In: Expert Opinion on Investigational Drugs. 27, 7, p. 601-611 11 p.

Research output: Contribution to journal › Review article › peer-review

24 Scopus citations

SOHO State of the Art Updates and Next Questions: Hodgkin Lymphoma

Watkins, M. P., Fanale, M. A. & Bartlett, N. L., Feb 2018, In: Clinical Lymphoma, Myeloma and Leukemia. 18, 2, p. 81-90 10 p.

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

2017

Hodgkin lymphoma: Current status and clinical trial recommendations

Diefenbach, C. S., Connors, J. M., Friedberg, J. W., Leonard, J. P., Kahl, B. S., Little, R. F., Baizer, L., Evens, A. M., Hoppe, R. T., Kelly, K. M., Persky, D. O., Younes, A., Kostakaglu, L. & Bartlett, N. L., Apr 2017, In: Journal of the National Cancer Institute. 109, 4

Research output: Contribution to journal › Review article › peer-review

Open Access

29 Scopus citations

NCCN guidelines® insights chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017: Featured updates to the NCCN guidelines

Wierda, W. G., Zelenetz, A. D., Gordon, L. I., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Caimi, P., Fayad, L. E., Fisher, R. I., Glenn, M. J., Habermann, T. M., Harris, N. L., Hernandez-Ilizaliturri, F., Hoppe, R. T., Horwitz, S. M., Kaminski, M. S., Kelsey, C. R. & Kim, Y. H. & 18 others, Krivacic, S., LaCasce, A. S., Martin, M. G., Nademanee, A., Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Roberts, K., Saad, A. A., Snyder, E. D., Sokol, L., Swinnen, L. J., Vose, J. M., Yahalom, J., Dwyer, M. A. & Sundar, H., Mar 1 2017, In: JNCCN Journal of the National Comprehensive Cancer Network. 15, 3, p. 293-311 19 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

51 Scopus citations

2016

Diffuse large b-cell lymphoma version 1.2016: Clinical practice guidelines in oncology

Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Fayad, L. E., Fisher, R. I., Glenn, M. J., Habermann, T. M., Harris, N. L., Hernandez-Ilizaliturri, F., Hoppe, R. T., Horwitz, S. M., Kaminski, M. S., Kelsey, C. R., Kim, Y. H. & Krivacic, S. & 17 others, LaCasce, A. S., Lunning, M., Nademanee, A., Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Roberts, K., Saad, A. A., Sokol, L., Swinnen, L. J., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M. & Sundar, H., Feb 1 2016, In: JNCCN Journal of the National Comprehensive Cancer Network. 14, 2, p. 196-231 36 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

78 Scopus citations

NCCN Guidelines® insights: Non-Hodgkin's lymphomas, version 3.2016 featured updates to the NCCN guidelines

Horwitz, S. M., Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Fayad, L. E., Fisher, R. I., Glenn, M. J., Habermann, T. M., Harris, N. L., Hernandez-Ilizaliturri, F., Hoppe, R. T., Kaminski, M. S., Kelsey, C. R., Kim, Y. H. & Krivacic, S. & 17 others, La Casce, A. S., Lunning, M., Nademanee, A., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Roberts, K., Saad, A. A., Sokol, L., Swinnen, L. J., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M., Sundar, H. & Porcu, P., Sep 2016, In: JNCCN Journal of the National Comprehensive Cancer Network. 14, 9, p. 1067-1079 13 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

116 Scopus citations

2015

Biologic agents in the management of Hodgkin lymphoma

Rashidi, A. & Bartlett, N. L., May 1 2015, In: JNCCN Journal of the National Comprehensive Cancer Network. 13, 5, p. 587-596 10 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

5 Scopus citations

Blinatumomab for the treatment of B-cell lymphoma

Oak, E. & Bartlett, N. L., May 1 2015, In: Expert Opinion on Investigational Drugs. 24, 5, p. 715-724 10 p.

Research output: Contribution to journal › Review article › peer-review

33 Scopus citations

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015

Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Fisher, R. I., Glenn, M. J., Habermann, T. M., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., Krivacic, S. & LaCasce, A. S. & 16 others, Nademanee, A., Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Saad, A. A., Sokol, L., Swinnen, L. J., Tsien, C., Vose, J. M., Wilson, L., Yahalom, J., Zafar, N., Dwyer, M. & Sundar, H., Mar 1 2015, In: JNCCN Journal of the National Comprehensive Cancer Network. 13, 3, p. 326-362 37 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

50 Scopus citations

2014

Non-Hodgkin's lymphomas, version 2.2014

Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Fisher, R. I., Glenn, M. J., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., Krivacic, S. & LaCasce, A. S. & 14 others, Nademanee, A., Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Sokol, L., Swinnen, L. J., Tsien, C., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M. & Sundar, H., Jun 1 2014, In: JNCCN Journal of the National Comprehensive Cancer Network. 12, 6, p. 916-946 31 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

59 Scopus citations

Non-Hodgkin's lymphomas, version 4.2014

Zelenetz, A. D., Gordon, L. I., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Fisher, R. I., Glenn, M. J., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., Krivacic, S., LaCasce, A. S. & Nademanee, A. & 14 others, Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Saad, A. A., Sokol, L., Swinnen, L. J., Tsien, C., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M. & Sundar, H., Sep 1 2014, In: JNCCN Journal of the National Comprehensive Cancer Network. 12, 9, p. 1282-1303 22 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

104 Scopus citations

Rituximab is associated with improved survival in Burkitt lymphoma: A retrospective analysis from two US academic medical centers

Wildes, T. M., Farrington, L., Yeung, C., Harrington, A. M., Foyil, K. V., Liu, J., Bartlett, N. L., Kreisel, F. & Fenske, T. S., Feb 2014, In: Therapeutic Advances in Hematology. 5, 1, p. 3-12 10 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

20 Scopus citations

2013

Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy

Bartlett, N. L., 2013, In: American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. p. 374-380 7 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

6 Scopus citations

Non-Hodgkin's lymphomas, version 1.2013: Featured updates to the NCCN guidelines

Zelenetz, A. D., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Glenn, M. J., Gockerman, J. P., Gordon, L. I., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Christopher, R. K., Kim, Y. H., Krivacic, S. & LaCasce, A. S. & 13 others, Nademanee, A., Porcu, P., Press, O., Pro, B., Reddy, N., Sokol, L., Swinnen, L., Tsien, C., Vose, J. M., Yahalom, J., Zafar, N., Dwyer, M. A. & Naganuma, M., Mar 1 2013, In: JNCCN Journal of the National Comprehensive Cancer Network. 11, 3, p. 257-273 17 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

56 Scopus citations

Treatment of nodular lymphocyte-predominant hodgkinlymphoma-"do no harm"

Bartlett, N. L., Jun 2013, In: Clinical Advances in Hematology and Oncology. 11, 6

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

2012

Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma

Foyil, K. V. & Bartlett, N. L., Sep 2012, In: Cancer Journal (United States). 18, 5, p. 450-456 7 p.

Research output: Contribution to journal › Review article › peer-review

49 Scopus citations

Commentary

Bartlett, N. L., Jul 1 2012, In: Clinical Advances in Hematology and Oncology. 10, 7, p. 470-471 2 p.

Research output: Contribution to journal › Review article › peer-review

Non-Hodgkin's Lymphomas, version 3.2012: Featured updates to the NCCN guidelines

Zelenetz, A. D., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L., Glenn, M. J., Gockerman, J. P., Gordon, L. I., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., Krivacic, S. & LaCasce, A. S. & 13 others, Nademanee, A., Porcu, P., Press, O., Pro, B., Reddy, N., Sokol, L., Swinnen, L., Tsien, C., Vose, J. M., Yahalom, J., Zafar, N., Naganuma, M. & Dwyer, M. A., Dec 1 2012, In: JNCCN Journal of the National Comprehensive Cancer Network. 10, 12, p. 1487-1498 12 p.

Research output: Contribution to journal › Review article › peer-review

32 Scopus citations

2011

Brentuximab vedotin for the treatment of CD30⁺ lymphomas

Foyil, K. V. & Bartlett, N. L., Apr 2011, In: Immunotherapy. 3, 4, p. 475-485 11 p.

Research output: Contribution to journal › Review article › peer-review

37 Scopus citations

Non-Hodgkin's lymphomas: Clinical practice guidelines in oncology

Zelenetz, A. D., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Glenn, M. J., Gockerman, J. P., Gordon, L. I., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Kelsey, C. R., Kim, Y. H., LaCasce, A. S., Nademanee, A. & Porcu, P. & 10 others, Press, O., Pro, B., Reddy, N., Sokol, L., Swinnen, L. J., Tsien, C., Vose, J. M., Wierda, W. G., Yahalom, J. & Zafar, N., May 1 2011, In: JNCCN Journal of the National Comprehensive Cancer Network. 9, 5, p. 484-560 77 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

61 Scopus citations

2010